Semaglutide and tirzepatide efficacy in weight loss comparison This is where the two drugs diverge most clearly, and where the most robust clinical evidence now exists
Following GLP1 treatment, participants reported having lost a median of 4.1 kg m 2 units of BMI (or 11.3 kg of weight), equivalent to a median of 11.7% of pre-treatment weight
Personalized Injection Strategy: The Role of Genetic Factors in GLP-1 Response Your genetic makeup influences how efficiently your body processes semaglutide and how well you tolerate the medication at various dose levels
Medications should only be used cautiously, in the lowest effective doses, and as an add-on to an individualized, health-promoting nutrition plan that includes a specific approach to weight loss maintenance, especially if discontinuing a GLP-1
It does not constitute medical advice, diagnosis, or treatment recommendations